This week, we are thrilled to introduce our newest team member, Fredrika Juhlin, who joins us as an HR Generalist. Fredrika comes to us with a strong background as an HR Consultant and an impressive tenure in London, […]
Data that’s not fit-for-purpose can be scary, but here’s the good news – Nordic data has many characteristics that allow it to be considered high-quality for a wide range of purposes. These include:
✔️ Complete population coverage for administrative (claims-type) data
✔️ […]
In the pharmaceutical industry, evidence reviews are crucial for various activities such as HTA & reimbursement, regulatory submissions, RWE strategic planning, evidence gap identification, and GVD development.
Leverage the expertise of our Evidence Review & Synthesis team to determine the most […]
How has the Western Pacific Region progressed towards the World Health Organization’s goals for psoriasis care? Find out in the IFPA’s (International Federation for Psoriasis Associations) recently published Index Report, co-authored by Quantify Research!
In the report, […]
Last week, our very own Mary Rosenzweig had the privilege of attending Bech-Bruun’s “Life Science Forum 2023 – the EU’s Revision of the Pharmaceutical Regulations” in Denmark. This event gathered prominent figures from the industry to discuss […]
ISPOREurope is fast approaching, and the Quantify Research team is looking forward to meeting with our current and future collaborators as well as presenting a wide variety of research.
Quantify will have a large group of in-house experts with diverse experience and […]
Since 2020, Quantify Research has been a proud partner to the European Medicines Agency coordinated ENCePP (European NEtwork for Centers of Pharmacoepidemiology and Pharmacovigilance) initiative.
This network brings together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe with […]
Using 10 years of national surveillance data from four Nordic countries, Quantify Research in collaboration with Pfizer found that a substantial amount of vaccine-preventable invasive pneumococcal disease remains present in elderly populations, despite the inclusion of pneumococcal conjugate […]
That’s a possible conclusion to draw from Sweden’s HTA body The Dental and Pharmaceutical Benefits Agency, TLV‘s report published this week, on the topic of improving access to drugs for rare diseases.https://www.linkedin.com/company/tlv-the-dental-and-pharmaceutical-benefits-agency/
The pharmaceutical market has shifted in […]
Don’t miss it!
On October 4th and 5th, Quantify Research’s CEO Kirk Geale and Lead Analyst Alexander Rieem Dun will be instructing the ISPOR—The Professional Society for […]
